$346 Million is the total value of Ghost Tree Capital, LLC's 47 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 67.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SER TRput | $50,255,000 | +49.6% | 451,000 | +50.3% | 14.52% | +63.9% |
| Buy | TRILLIUM THERAPEUTICS INC | $27,710,000 | +124.6% | 1,950,000 | +27.9% | 8.01% | +146.1% | |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $20,062,000 | +108.7% | 130,000 | +100.0% | 5.80% | +128.5% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $19,551,000 | +33.7% | 1,050,000 | +68.0% | 5.65% | +46.4% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $18,929,000 | +18.9% | 575,000 | -0.9% | 5.47% | +30.2% |
| IMVT | IMMUNOVANT INC | $18,475,000 | +44.5% | 525,000 | 0.0% | 5.34% | +58.3% | |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $14,689,000 | -24.8% | 725,000 | +11.5% | 4.25% | -17.6% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $11,962,000 | -36.3% | 1,161,375 | +29.0% | 3.46% | -30.3% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $9,963,000 | -43.7% | 60,000 | -61.3% | 2.88% | -38.3% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $9,263,000 | +122.1% | 1,250,000 | +25.0% | 2.68% | +143.4% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $9,144,000 | -32.8% | 400,000 | -38.5% | 2.64% | -26.4% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $9,128,000 | – | 65,000 | +100.0% | 2.64% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $8,472,000 | – | 600,000 | +100.0% | 2.45% | – |
| AUPH | AURINIA PHARMACEUTICALS INC | $8,102,000 | -9.4% | 550,000 | 0.0% | 2.34% | -0.7% | |
| FATE | Buy | FATE THERAPEUTICS INC | $7,994,000 | +86.4% | 200,000 | +60.0% | 2.31% | +104.1% |
| SURF | Buy | SURFACE ONCOLOGY INC | $6,900,000 | +50.3% | 1,000,000 | +42.9% | 1.99% | +64.5% |
| KURA | New | KURA ONCOLOGY INC | $6,894,000 | – | 225,000 | +100.0% | 1.99% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $6,698,000 | -26.0% | 1,950,000 | +2.6% | 1.94% | -19.0% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,273,000 | +128.8% | 425,000 | +129.7% | 1.81% | +150.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $6,125,000 | -0.4% | 175,000 | +52.2% | 1.77% | +9.1% |
| ISEE | Buy | IVERIC BIO INC | $5,640,000 | +22.9% | 1,000,000 | +11.1% | 1.63% | +34.6% |
| TGTX | Sell | TG THERAPEUTICS INC | $5,352,000 | -54.2% | 200,000 | -66.7% | 1.55% | -49.8% |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $5,027,000 | – | 805,556 | +100.0% | 1.45% | – |
| IMUX | New | IMMUNIC INC | $4,921,000 | – | 265,000 | +100.0% | 1.42% | – |
| ARVN | Buy | ARVINAS INC | $4,722,000 | +17.3% | 200,000 | +66.7% | 1.36% | +28.5% |
| KALV | KALVISTA PHARMACEUTICALS INC | $4,407,000 | +4.1% | 350,000 | 0.0% | 1.27% | +14.1% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,158,000 | -37.6% | 825,000 | 0.0% | 1.20% | -31.7% | |
| RAPT | New | RAPT THERAPEUTICS INC | $3,703,000 | – | 115,000 | +100.0% | 1.07% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $3,608,000 | -35.2% | 425,000 | -20.6% | 1.04% | -29.0% |
| XENE | XENON PHARMACEUTICALS INC | $3,598,000 | -11.7% | 325,000 | 0.0% | 1.04% | -3.3% | |
| NXTC | New | NEXTCURE INC | $3,520,000 | – | 400,000 | +100.0% | 1.02% | – |
| MYOV | Sell | MYOVANT SCIENCES LTD | $3,513,000 | -43.2% | 250,000 | -16.7% | 1.02% | -37.8% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $2,923,000 | -62.5% | 30,000 | -40.0% | 0.84% | -58.9% |
| ALT | Buy | ALTIMMUNE INC | $2,640,000 | +64.3% | 200,000 | +33.3% | 0.76% | +80.0% |
| RGNX | New | REGENXBIO INC | $2,064,000 | – | 75,000 | +100.0% | 0.60% | – |
| MLND | New | MILLENDO THERAPEUTICS INC | $1,508,000 | – | 925,000 | +100.0% | 0.44% | – |
| FIXX | Sell | HOMOLOGY MEDICINES INC | $1,445,000 | -59.5% | 135,000 | -42.6% | 0.42% | -55.6% |
| IMV | New | IMV INC | $1,443,000 | – | 325,000 | +100.0% | 0.42% | – |
| BIIB | New | BIOGEN INC | $1,191,000 | – | 4,200 | +100.0% | 0.34% | – |
| GRAY | New | GRAYBUG VISION INC | $953,000 | – | 75,000 | +100.0% | 0.28% | – |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $778,000 | -92.0% | 200,000 | -41.2% | 0.22% | -91.3% |
| MRNA | MODERNA INC | $708,000 | +10.3% | 10,000 | 0.0% | 0.20% | +21.3% | |
| AKBA | New | AKEBIA THERAPEUTICS INC | $628,000 | – | 250,000 | +100.0% | 0.18% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $421,000 | – | 100,000 | +100.0% | 0.12% | – |
| BMYRT | New | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $281,000 | – | 125,000 | +100.0% | 0.08% | – |
| CCXI | New | CHEMOCENTRYX INC | $247,000 | – | 4,500 | +100.0% | 0.07% | – |
| FXE | Exit | INVESCO CURRENCYSHARES EURO | $0 | – | -2,000 | -100.0% | -0.06% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -300,000 | -100.0% | -0.18% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -50,000 | -100.0% | -0.34% | – |
| PYPD | Exit | POLYPID LTD | $0 | – | -100,000 | -100.0% | -0.48% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -25,000 | -100.0% | -0.51% | – |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -1,000,000 | -100.0% | -0.75% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -165,000 | -100.0% | -2.11% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -2.17% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -125,000 | -100.0% | -2.54% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -50,000 | -100.0% | -3.26% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -385,000 | -100.0% | -3.38% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -65,000 | -100.0% | -5.29% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -575,000 | -100.0% | -5.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.